Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) today announced the appointment of Kathy Rouan, PhD, to the Company’s board of directors, effective ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE